No serological evidence of Rickettsia helvetica infection in Scandinavian sarcoidosis patients

Planck A., Eklund A., Grunewald J., Vene S.

Source: Eur Respir J 2004; 24 : 811-813
Journal Issue: November

Congress or journal article abstractPDF journal article, handout or slidesFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Planck A., Eklund A., Grunewald J., Vene S.. No serological evidence of Rickettsia helvetica infection in Scandinavian sarcoidosis patients. Eur Respir J 2004; 24 : 811-813

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Coxiella burnetii pneumonia
Source: Eur Respir J 2003; 21: 713-719
Year: 2003



Serological evidence of Legionella species infection in acute exacerbation of COPD
Source: Eur Respir J 2002; 20: 504-505
Year: 2002


Tularaemia
Source: Eur Respir J 2003; 21: 361-373
Year: 2003



Serodiagnosis of mycobacterium avium-complex pulmonary disease using anti-glycopeptidolipid core antigen IgA antibody
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013


Pulmonary manifestations of toxocara canis larval infection in adults
Source: Eur Respir J 2004; 24: Suppl. 48, 356s
Year: 2004

Macrolide-resistant mycoplasma pneumoniae in respiratory tract infection and its clinical relevance
Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections
Year: 2016


Clinical relevance of Mycobacterium simiae in pulmonary samples
Source: Eur Respir J 2008; 31: 106-109
Year: 2008



The role of Chlamydiae spp. in respiratory infections
Source: Annual Congress 2005 - Difficult infections in the respiratory patient
Year: 2005

Prevalance of chlamydia, mycoplasma, legionella and influenza A antibodies in acute exacerbation of COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 484s
Year: 2001

Chlamydia species as a cause of community-acquired pneumonia in Canada
Source: Eur Respir J 2003; 21: 779-784
Year: 2003



The first case of mycobacterium shimoidei infection in the UK
Source: Annual Congress 2011 - Clinical challenges in tuberculosis
Year: 2011

Co-infection by pneumocystis jirovecii and histoplasma capsulatum presenting with pulmonary miliary pattern in an HIV positive young male
Source: International Congress 2015 – Immunodepression and severe pneumonia
Year: 2015

Clinical and laboratory features of Mycobacterium avium complex infection in comparison with infection, caused by Mycobacterium tuberculosis, in HIV-infected patients
Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II
Year: 2019


Role of persistent infection in the control and severity of asthma: focus on Chlamydia pneumoniae
Source: Eur Respir J 2002; 19: 546-556
Year: 2002



Atypical pathogens and respiratory tract infections
Source: Eur Respir J 2004; 24: 171-182
Year: 2004



Secondary pulmonary mycoses etiology agent species diversity in patients with tuberculosis and in patients with HIV infection
Source: Virtual Congress 2020 – Mechanism or pathways of chronic lung diseases
Year: 2020


Detection of Rickettsia in archival tissue samples from Danish patients with sarcoidosis
Source: Annual Congress 2008 - Clinical aspects in the management of sarcoidosis
Year: 2008


Mycobacterium tilburgii infection in an HIV-seropositive host
Source: Annual Congress 2009 - Tuberculosis and HIV co-infection
Year: 2009


Response to Rv2628 latency antigen associates with cured tuberculosis and remote infection
Source: Eur Respir J 2010; 36: 135-142
Year: 2010